While blood plasma levels of troponin subunits cTnI and cTnT are currently used as diagnostic markers for myocardial infarction [110–112], troponin may also have potential diagnostic and prognostic utility in oncology as a genetic biomarker for a subset of cancers [113]. Here, TNNT2 is linked to cancer.